SGMO
Sangamo Therapeutics·NASDAQ
--
--(--)
--
--(--)
SGMO fundamentals
During Q4 2025, Sangamo Therapeutics (SGMO) reported revenue of 14.23M, a YoY change of 88.43%. Net income was -37.42M, a YoY change of -59.94%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2015 | Q3,2015 | Q4,2015 | Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Apr 1, 2015 | Jul 1, 2015 | Oct 1, 2015 | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Jun 30, 2015 | Sep 30, 2015 | Dec 31, 2015 | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 8.36M -- | 8.57M -- | 9.12M -- | 3.94M -- | 3.70M -55.71% | 2.82M -67.06% | 8.92M -2.18% | 3.42M -13.12% | 8.25M +122.93% | 11.81M +318.42% | 13.08M +46.57% | 12.64M +268.96% | 21.42M +159.49% | 23.56M +99.48% | 26.84M +105.22% | 8.07M -36.13% | 17.55M -18.06% | 21.96M -6.81% | 54.85M +104.39% | 13.08M +62.01% | 21.55M +22.82% | 57.76M +163.06% | 25.80M -52.96% | 26.28M +100.98% | 27.87M +29.32% | 28.56M -50.55% | 27.99M +8.47% | 28.23M +7.42% | 29.38M +5.40% | 26.46M -7.36% | 27.23M -2.70% | 157.96M +459.52% | 6.83M -76.73% | 9.40M -64.48% | 2.04M -92.50% | 481.00K -99.70% | 356.00K -94.79% | 49.41M +425.77% | 7.55M +269.78% | 6.44M +1238.25% | 18.31M +5042.13% | 581.00K -98.82% | 14.23M +88.43% | 39.55M -- |
Sales and Services Revenue | 8.36M -- | 8.57M -- | 9.12M -- | 3.94M -- | 3.70M -55.71% | 2.82M -67.06% | 8.92M -2.18% | 3.42M -13.12% | 8.25M +122.93% | 11.81M +318.42% | 13.08M +46.57% | 12.64M +268.96% | 21.42M +159.49% | 23.56M +99.48% | 26.84M +105.22% | 8.07M -36.13% | 17.55M -18.06% | 21.96M -6.81% | 54.85M +104.39% | 13.08M +62.01% | 21.55M +22.82% | 57.76M +163.06% | 25.80M -52.96% | 26.28M +100.98% | 27.87M +29.32% | 28.56M -50.55% | 27.99M +8.47% | 28.23M +7.42% | 29.38M +5.40% | 26.46M -7.36% | 27.23M -2.70% | 157.96M +459.52% | 6.83M -76.73% | 9.40M -64.48% | 2.04M -92.50% | 481.00K -99.70% | 356.00K -94.79% | 49.41M +425.77% | 7.55M +269.78% | 6.44M +1238.25% | 18.31M +5042.13% | 581.00K -98.82% | 14.23M +88.43% | 39.55M -- |
Cost of Revenue | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | 8.36M -- | 8.57M -- | 9.12M -- | 3.94M -- | 3.70M -55.71% | 2.82M -67.06% | 8.92M -2.18% | 3.42M -13.12% | 8.25M +122.93% | 11.81M +318.42% | 13.08M +46.57% | 12.64M +268.96% | 21.42M +159.49% | 23.56M +99.48% | 26.84M +105.22% | 8.07M -36.13% | 17.55M -18.06% | 21.96M -6.81% | 54.85M +104.39% | 13.08M +62.01% | 21.55M +22.82% | 57.76M +163.06% | -92.39M -268.44% | 26.28M +100.98% | 27.87M +29.32% | 28.56M -50.55% | -82.72M +10.47% | 28.23M +7.42% | 29.38M +5.40% | 26.46M -7.36% | -84.07M -1.64% | 157.96M +459.52% | 6.83M -76.73% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 20.64M -- | 21.25M -- | 24.79M -- | 20.62M -- | 30.54M +48.02% | 22.03M +3.65% | 18.75M -24.37% | 20.22M -1.97% | 21.02M -31.18% | 24.85M +12.79% | 26.84M +43.15% | 33.63M +66.36% | 40.56M +92.93% | 39.80M +60.19% | 47.61M +77.36% | 51.97M +54.51% | 51.05M +25.88% | 51.21M +28.65% | 53.38M +12.13% | 57.60M +10.83% | 59.45M +16.45% | 61.46M +20.03% | 69.23M +29.69% | 72.58M +26.01% | 76.57M +28.80% | 77.00M +25.27% | 67.89M -1.95% | 73.49M +1.25% | 75.11M -1.91% | 81.35M +5.66% | 82.62M +21.71% | 139.92M +90.39% | 130.41M +73.62% | 115.81M +42.35% | 64.10M -22.42% | 52.01M -62.83% | 37.44M -71.29% | 38.78M -66.51% | 33.54M -47.67% | 36.06M -30.65% | 36.16M -3.42% | 36.13M -6.83% | 52.43M +56.32% | 160.79M -- |
Selling, General and Administrative Expenses | 5.02M -- | 4.56M -- | 4.89M -- | 5.36M -- | 11.09M +121.05% | 5.02M +10.11% | 4.86M -0.53% | 7.28M +35.80% | 6.04M -45.56% | 6.42M +27.90% | 7.47M +53.56% | 10.09M +38.65% | 11.30M +87.20% | 10.99M +71.18% | 14.36M +92.27% | 17.12M +69.70% | 14.60M +29.17% | 14.92M +35.70% | 15.05M +4.86% | 16.12M -5.84% | 17.93M +22.81% | 16.18M +8.44% | 16.87M +12.10% | 16.15M +0.18% | 16.49M -8.04% | 14.50M -10.36% | 16.08M -4.68% | 14.91M -7.68% | 15.09M -8.45% | 16.24M +11.98% | 16.44M +2.23% | 18.14M +21.65% | 16.01M +6.10% | 13.92M -14.29% | 13.10M -20.34% | 11.77M -35.12% | 12.04M -24.78% | 11.05M -20.61% | 9.87M -24.68% | 10.06M -14.52% | 9.08M -24.64% | 7.99M -27.67% | 7.76M -21.37% | 34.89M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 67.10M -- | -- -- | -- -- | -- -- | 63.22M -5.78% | -- -- | -- -- | -- -- | 62.68M -0.85% | -- -- | -- -- | 13.92M -- | 13.10M -79.10% | 11.77M -- | 12.04M -- | 11.05M -20.61% | 9.87M -24.68% | 10.06M -14.52% | 9.08M -24.64% | 7.99M -27.67% | 7.76M -21.37% | 34.89M -- |
Research and Development Expenses | 15.62M -- | 16.69M -- | 19.91M -- | 15.27M -- | 19.45M +24.56% | 17.01M +1.88% | 13.89M -30.22% | 12.94M -15.22% | 14.98M -22.98% | 18.43M +8.33% | 19.38M +39.50% | 23.55M +81.94% | 29.25M +95.24% | 28.81M +56.36% | 33.25M +71.62% | 34.85M +48.00% | 36.45M +24.61% | 36.29M +25.96% | 38.33M +15.26% | 41.48M +19.02% | 41.52M +13.90% | 45.29M +24.80% | 52.36M +36.60% | 56.43M +36.05% | 60.09M +44.71% | 62.50M +38.00% | 51.80M -1.06% | 58.58M +3.81% | 60.02M -0.11% | 65.12M +4.19% | 66.18M +27.76% | 63.22M +7.91% | 63.05M +5.04% | 57.09M -12.33% | 50.71M -23.38% | 35.89M -43.22% | 24.22M -61.58% | 27.73M -51.42% | 23.68M -53.31% | 26.01M -27.54% | 27.08M +11.81% | 28.14M +1.48% | 31.44M +32.79% | 112.67M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 44.80M -- | 296.00K -- | 4.35M -- | 1.17M -- | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -- | 13.23M -- | 13.23M -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 58.57M -- | 51.35M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -12.28M -- | -12.69M -- | -15.67M -- | -16.68M -- | -26.84M -118.64% | -19.21M -51.41% | -9.83M +37.28% | -16.79M -0.67% | -12.77M +52.43% | -13.04M +32.13% | -13.77M -40.04% | -21.00M -25.04% | -19.14M -49.91% | -16.24M -24.60% | -20.77M -50.89% | -43.90M -109.06% | -33.50M -75.05% | -29.25M -80.09% | 1.47M +107.07% | -44.52M -1.42% | -37.90M -13.11% | -3.70M +87.35% | -43.43M -3056.57% | -46.30M -4.00% | -48.70M -28.51% | -48.44M -1208.73% | -39.90M +8.13% | -45.26M +2.25% | -45.73M +6.09% | -54.89M -13.33% | -55.39M -38.83% | 18.03M +139.84% | -123.57M -170.20% | -106.41M -93.84% | -62.06M -12.04% | -51.53M -385.72% | -37.08M +69.99% | 10.63M +109.99% | -25.99M +58.12% | -29.63M +42.50% | -17.86M +51.85% | -35.55M -434.43% | -38.20M -46.99% | -121.24M -- |
Non-Operating Income (Loss) | 151.00K -- | 101.00K -- | 25.00K -- | 187.00K -- | 243.00K +60.93% | 238.00K +135.64% | 219.00K +776.00% | 160.00K -14.44% | 277.00K +13.99% | 681.00K +186.13% | 675.00K +208.22% | 810.00K +406.25% | 2.50M +802.53% | 3.40M +398.97% | 1.55M +130.07% | 1.69M +109.14% | 3.15M +25.92% | 1.89M -44.47% | 3.03M +95.24% | 1.55M -8.62% | 1.93M -38.63% | 2.43M +28.78% | 2.87M -5.51% | 625.00K -59.63% | 1.55M -19.77% | 834.00K -65.68% | 2.34M -18.46% | 1.34M +114.72% | 2.64M +70.52% | 1.77M +112.11% | 3.68M +57.45% | 3.29M +145.38% | 2.80M +6.02% | 3.52M +98.70% | 1.49M -59.43% | 2.54M -23.02% | 1.03M -63.24% | 129.00K -96.33% | 2.17M +45.24% | -850.00K -133.53% | -2.10M -304.27% | 462.00K +258.14% | 231.00K -89.34% | -2.26M -- |
Other Non-Operating Income (Loss) | 151.00K -- | 101.00K -- | 25.00K -- | 187.00K -- | 243.00K +60.93% | 238.00K +135.64% | 219.00K +776.00% | 160.00K -14.44% | 277.00K +13.99% | 681.00K +186.13% | 675.00K +208.22% | 810.00K +406.25% | 2.50M +802.53% | 3.40M +398.97% | 1.55M +130.07% | 1.69M +109.14% | 3.15M +25.92% | 1.89M -44.47% | 3.03M +95.24% | 1.55M -8.62% | 1.93M -38.63% | 2.43M +28.78% | -5.91M -294.92% | 625.00K -59.63% | 1.55M -19.77% | 834.00K -65.68% | -3.01M +49.07% | 1.34M +114.72% | 2.64M +70.52% | 1.77M +112.11% | -5.75M -91.16% | 3.29M +145.38% | 2.80M +6.02% | -- -- | -- -- | 2.08M -36.71% | 614.00K -78.09% | -221.00K -- | 1.87M -- | -1.16M -155.61% | -2.49M -505.54% | 107.00K +148.42% | -21.00K -101.12% | -3.56M -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -8.78M -- | -- -- | -- -- | -- -- | -5.35M +39.08% | -- -- | -- -- | -- -- | -9.43M -76.43% | -- -- | -- -- | -3.52M -- | -1.49M +84.18% | -451.00K -- | -416.00K -- | -350.00K +90.04% | -296.00K +80.16% | -309.00K +31.49% | -386.00K +7.21% | -355.00K -1.43% | -252.00K +14.86% | -1.30M -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 8.78M -- | -- -- | -- -- | -- -- | 5.35M -39.08% | -- -- | -- -- | -- -- | 9.43M +76.43% | -- -- | -- -- | 3.52M -- | 1.49M -84.18% | 451.00K -- | 416.00K -- | 350.00K -90.04% | 296.00K -80.16% | 309.00K -31.49% | 386.00K -7.21% | 355.00K +1.43% | 252.00K -14.86% | 1.30M -- |
Pretax Income From Continuing Operations | -12.13M -- | -12.58M -- | -15.65M -- | -16.49M -- | -26.60M -119.36% | -18.97M -50.73% | -9.61M +38.58% | -16.63M -0.84% | -12.49M +53.04% | -12.35M +34.87% | -13.09M -36.21% | -20.19M -21.37% | -16.64M -33.22% | -12.84M -3.96% | -19.22M -46.81% | -42.20M -109.06% | -30.36M -82.43% | -27.36M -113.04% | 4.50M +123.42% | -42.97M -1.83% | -35.97M -18.48% | -1.27M +95.35% | -40.57M -1001.29% | -45.68M -6.29% | -47.15M -31.10% | -47.60M -3645.24% | -37.56M +7.41% | -43.92M +3.85% | -43.09M +8.61% | -53.13M -11.60% | -51.71M -37.67% | 21.33M +148.56% | -120.77M -180.27% | -102.89M -93.68% | -60.57M -17.12% | -48.99M -329.71% | -36.05M +70.15% | 10.76M +110.46% | -23.82M +60.67% | -30.48M +37.79% | -19.96M +44.64% | -35.09M -426.12% | -37.97M -59.39% | -123.50M -- |
Income Tax Expense | -- -- | -3.34M -- | -1.64M -- | -- -- | -24.00K -- | -3.00K +99.91% | 13.00K +100.80% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 237.00K -- | 108.00K -- | 262.00K -- | 24.00K -- | 86.00K -63.71% | -67.00K -162.04% | 58.00K -77.86% | 82.00K +241.67% | 30.00K -65.12% | 259.00K +486.57% | 194.00K +234.48% | -6.26M -7739.02% | 1.27M +4133.33% | -272.00K -205.02% | 98.00K -49.48% | 74.00K +101.18% | 88.00K -93.07% | -427.00K -56.99% | 119.00K +21.43% | 27.00K -63.51% | -161.00K -282.95% | -553.00K -29.51% | -568.00K -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 819.00K -- | -- -- | -- -- | -- -- | 886.00K +8.18% | -- -- | -- -- | -- -- | 500.00K -43.57% | -- -- | -- -- | -- -- | 186.00K -62.80% | -- -- | -- -- | -- -- | -167.00K -189.78% | -- -- | -- -- | -- -- | -568.00K -240.12% | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -474.00K -- | -- -- | -- -- | -- -- | -580.00K -22.36% | -- -- | -- -- | -- -- | -71.00K +87.76% | -- -- | -- -- | -- -- | -5.26M -7305.63% | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- |
Net Income | -12.13M -- | -9.24M -- | -14.01M -- | -16.49M -- | -26.57M -119.16% | -18.96M -105.14% | -9.62M +31.32% | -16.63M -0.84% | -12.49M +53.00% | -12.35M +34.86% | -13.09M -36.02% | -20.19M -21.37% | -16.64M -33.22% | -12.84M -3.96% | -19.22M -46.81% | -42.20M -109.06% | -30.36M -82.43% | -27.36M -113.04% | 4.50M +123.42% | -42.97M -1.83% | -35.97M -18.48% | -1.51M +94.49% | -40.67M -1003.69% | -45.94M -6.90% | -47.17M -31.17% | -47.69M -3062.33% | -37.50M +7.82% | -43.98M +4.27% | -43.17M +8.48% | -53.16M -11.46% | -51.97M -38.61% | 21.13M +148.05% | -114.51M -165.23% | -104.16M -95.96% | -60.30M -16.01% | -49.09M -332.29% | -36.13M +68.45% | 10.67M +110.25% | -23.40M +61.20% | -30.60M +37.67% | -19.99M +44.68% | -34.93M -427.31% | -37.42M -59.94% | -122.93M -- |
Net Income Attributable to Minority Interests | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | 0 -- | -555.00K -- | -53.00K -- | -72.00K -- | -54.00K -- | -54.00K +90.27% | -61.00K -15.09% | -36.00K +50.00% | 42.00K +177.78% | -71.00K -31.48% | -6.00K +90.16% | -5.00K +86.11% | 0 -100.00% | 0 +100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Owners of the Company | -12.13M -- | -9.24M -- | -14.01M -- | -16.49M -- | -26.57M -119.16% | -18.96M -105.14% | -9.62M +31.32% | -16.63M -0.84% | -12.49M +53.00% | -12.35M +34.86% | -13.09M -36.02% | -20.19M -21.37% | -16.64M -33.22% | -12.84M -3.96% | -18.66M -42.57% | -42.15M -108.80% | -30.28M -82.00% | -27.31M -112.62% | 4.55M +124.41% | -42.91M -1.81% | -35.93M -18.64% | -1.55M +94.32% | -40.60M -991.42% | -45.93M -7.04% | -47.17M -31.28% | -47.69M -2976.65% | -37.50M +7.65% | -43.98M +4.26% | -43.17M +8.47% | -53.16M -11.46% | -51.97M -38.61% | 21.13M +148.05% | -114.51M -165.23% | -104.16M -95.96% | -60.30M -16.01% | -49.09M -332.29% | -36.13M +68.45% | 10.67M +110.25% | -23.40M +61.20% | -30.60M +37.67% | -19.99M +44.68% | -34.93M -427.31% | -37.42M -59.94% | -122.93M -- |
Other Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 1.29M -- | 0 -- | -- -- | -- -- | 0 -100.00% | 0 -- | -- -- |
Net Income Attributable to Common Stockholders | -12.13M -- | -9.24M -- | -14.01M -- | -16.49M -- | -26.57M -119.16% | -18.96M -105.14% | -9.62M +31.32% | -16.63M -0.84% | -12.49M +53.00% | -12.35M +34.86% | -13.09M -36.02% | -20.19M -21.37% | -16.64M -33.22% | -12.84M -3.96% | -18.66M -42.57% | -42.15M -108.80% | -30.28M -82.00% | -27.31M -112.62% | 4.55M +124.41% | -42.91M -1.81% | -35.93M -18.64% | -1.55M +94.32% | -40.60M -991.42% | -45.93M -7.04% | -47.17M -31.28% | -47.69M -2976.65% | -37.50M +7.65% | -43.98M +4.26% | -43.17M +8.47% | -53.16M -11.46% | -51.97M -38.61% | 21.13M +148.05% | -114.51M -165.23% | -104.16M -95.96% | -60.30M -16.01% | -49.09M -332.29% | -36.13M +68.45% | 9.38M +109.01% | -23.40M +61.20% | -30.60M +37.67% | -19.99M +44.68% | -34.93M -472.19% | -37.42M -59.94% | -122.93M -- |
Other Comprehensive Income | -28.00K -- | 57.00K -- | -54.00K -- | 83.00K -- | 8.00K +128.57% | -14.00K -124.56% | -57.00K -5.56% | -112.00K -234.94% | -51.00K -737.50% | 12.00K +185.71% | -175.00K -207.02% | -99.00K +11.61% | 230.00K +550.98% | -87.00K -825.00% | -1.22M -594.29% | -1.25M -1163.64% | 1.93M +737.39% | -4.14M -4654.02% | 2.45M +301.81% | -1.38M -10.23% | 2.17M +12.93% | 3.21M +177.51% | 3.87M +57.67% | -4.71M -241.19% | 1.27M -41.47% | -2.61M -181.41% | -3.36M -187.02% | -2.97M +36.92% | -6.21M -587.43% | -5.84M -123.68% | 10.59M +414.92% | 2.65M +189.15% | -178.00K +97.13% | -645.00K +88.95% | 1.99M -81.25% | -1.21M -145.58% | -82.00K +53.93% | 1.66M +357.36% | -3.31M -266.52% | 2.00M +266.09% | 4.07M +5060.98% | 14.00K -99.16% | -19.00K +99.43% | 6.07M -- |
Total Comprehensive Income | -12.15M -- | -9.19M -- | -14.07M -- | -16.41M -- | -26.57M -118.59% | -18.98M -106.56% | -9.68M +31.18% | -16.74M -2.03% | -12.54M +52.79% | -12.34M +34.97% | -13.27M -37.03% | -20.29M -21.15% | -16.41M -30.84% | -12.93M -4.76% | -20.43M -54.03% | -43.45M -114.21% | -28.43M -73.25% | -31.50M -143.60% | 6.95M +134.03% | -44.35M -2.07% | -33.79M -18.85% | 1.70M +105.39% | -36.81M -629.40% | -50.64M -14.18% | -45.90M -35.84% | -50.30M -3062.19% | -40.86M -11.01% | -46.95M +7.30% | -49.38M -7.57% | -58.99M -17.29% | -41.38M -1.27% | 23.78M +150.65% | -114.68M -132.26% | -104.81M -77.66% | -58.31M -40.91% | -50.30M -311.51% | -36.21M +68.43% | 12.33M +111.77% | -26.70M +54.20% | -28.59M +43.15% | -15.92M +56.04% | -34.92M -383.13% | -37.44M -40.20% | -116.87M -- |
Total Comprehensive Income Attributable to Minority Interests | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | 0 -- | -574.00K -- | -53.00K -- | -72.00K -- | -54.00K -- | -54.00K +90.59% | -61.00K -15.09% | -36.00K +50.00% | 42.00K +177.78% | -71.00K -31.48% | -6.00K +90.16% | -5.00K +86.11% | 0 -100.00% | 0 +100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -12.15M -- | -9.19M -- | -14.07M -- | -16.41M -- | -26.57M -118.59% | -18.98M -106.56% | -9.68M +31.18% | -16.74M -2.03% | -12.54M +52.79% | -12.34M +34.97% | -13.27M -37.03% | -20.29M -21.15% | -16.41M -30.84% | -12.93M -4.76% | -19.86M -49.71% | -43.40M -113.95% | -28.36M -72.81% | -31.44M -143.18% | 7.01M +135.28% | -44.29M -2.05% | -33.75M -19.03% | 1.66M +105.27% | -36.74M -624.30% | -50.64M -14.33% | -45.90M -35.97% | -50.30M -3137.32% | -40.86M -11.22% | -46.95M +7.29% | -49.38M -7.59% | -58.99M -17.29% | -41.38M -1.27% | 23.78M +150.65% | -114.68M -132.26% | -104.81M -77.66% | -58.31M -40.91% | -50.30M -311.51% | -36.21M +68.43% | 12.33M +111.77% | -26.70M +54.20% | -28.59M +43.15% | -15.92M +56.04% | -34.92M -383.13% | -37.44M -40.20% | -116.87M -- |
Basic EPS | -0.17 -- | -0.13 -- | -- -- | -0.23 -- | -0.38 -123.53% | -0.27 -107.69% | -0.14 -- | -0.23 -- | -0.17 +55.26% | -0.15 +44.44% | -0.15 -7.14% | -0.23 -- | -0.17 -- | -0.13 +13.33% | -0.18 -20.00% | -0.41 -78.26% | -0.26 -52.94% | -0.24 -84.62% | 0.04 +122.22% | -0.37 +9.76% | -0.26 -- | -0.01 +95.83% | -0.29 -825.00% | -0.32 +13.51% | -0.33 -26.92% | -0.33 -3200.00% | -0.26 +10.34% | -0.3 +6.25% | -0.29 +12.12% | -0.34 -3.03% | -0.31 -19.23% | 0.13 +143.33% | -0.66 -127.59% | -0.59 -73.53% | -0.34 -9.68% | -0.27 -307.69% | -0.18 +72.73% | 0.05 +108.47% | -0.11 +67.65% | -0.14 +48.15% | -0.08 +55.56% | -0.11 -320.00% | -0.11 -- | -0.44 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.59 -- | -- -- | -0.27 -- | -0.18 -- | 0.05 +108.47% | -- -- | -0.14 +48.15% | -0.08 +55.56% | -0.11 -320.00% | -- -- | -- -- |
Diluted EPS | -0.17 -- | -0.13 -- | -- -- | -0.23 -- | -0.38 -123.53% | -0.27 -107.69% | -- -- | -0.23 -- | -0.17 +55.26% | -0.15 +44.44% | -- -- | -0.23 -- | -0.17 -- | -0.13 +13.33% | -- -- | -0.41 -78.26% | -0.26 -52.94% | -0.24 -84.62% | -- -- | -0.37 +9.76% | -0.26 -- | -0.01 +95.83% | -- -- | -0.32 +13.51% | -0.33 -26.92% | -0.33 -3200.00% | -- -- | -0.3 +6.25% | -0.29 +12.12% | -0.34 -3.03% | -- -- | 0.12 +140.00% | -0.66 -127.59% | -0.59 -73.53% | -- -- | -0.27 -325.00% | -0.18 +72.73% | 0.04 +106.78% | -- -- | -0.14 +48.15% | -0.08 +55.56% | -0.11 -375.00% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.59 -- | -- -- | -0.27 -- | -0.18 -- | 0.04 +106.78% | -- -- | -0.14 +48.15% | -0.08 +55.56% | -0.11 -375.00% | -- -- | -- -- |
You can ask Aime
What is the revenue and EPS growth rate for Sangamo Therapeutics year over year?What guidance did Sangamo Therapeutics's management provide for the next earnings period?What is Sangamo Therapeutics's latest dividend and current dividend yield?What factors drove the changes in Sangamo Therapeutics's revenue and profit?Did Sangamo Therapeutics beat or miss consensus estimates last quarter?What does Sangamo Therapeutics do and what are its main business segments?What were the key takeaways from Sangamo Therapeutics’s earnings call?What is the market's earnings forecast for Sangamo Therapeutics next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
